MCLAUGHLIN MATTHEW T E (Chief Financial Officer) received a stock award from OXFORD IMMUNOTEC GLOBAL PLC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/13/2020ACC: 0001437749-20-005160
Officer· Chief Financial Officer
Since Apr 2019
+69.59K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
69.59K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+34.80K
Price / share
—
Trade value
—
% of position
130.7%
3/11/2020
26.61K→61.41K
Total
Net shares
+34.80K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/11/2020 | A · Award | +34.80K | — | — | 130.7% | 26.61K | 61.41K |
| Total | +34.80K | $0.00 | ||||||
Derivative Transactions1
Share Option (Right to Buy)
Direct
Converts to
Ordinary Shares
34.80K shares
Shares
+34.80K
Strike price
12.19
Held after
34.80K
Exercisable
—
3/11/2020
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy) Direct | Ordinary Shares34.80K shares | 3/11/2020 | A · Award | +34.80K | 12.19 | — | 34.80K |